Fujian Cosunter Pharmaceutical Third Quarter 2024 Earnings: CN¥0.22 loss per share (vs CN¥0.24 loss in 3Q 2023)

Simply Wall St · 10/26 00:17

Fujian Cosunter Pharmaceutical (SZSE:300436) Third Quarter 2024 Results

Key Financial Results

  • Revenue: CN¥108.1m (up 5.8% from 3Q 2023).
  • Net loss: CN¥34.6m (loss narrowed by 10% from 3Q 2023).
  • CN¥0.22 loss per share (improved from CN¥0.24 loss in 3Q 2023).
earnings-and-revenue-history
SZSE:300436 Earnings and Revenue History October 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Fujian Cosunter Pharmaceutical shares are up 15% from a week ago.

Risk Analysis

You still need to take note of risks, for example - Fujian Cosunter Pharmaceutical has 3 warning signs we think you should be aware of.